BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31746434)

  • 1. Long non‑coding RNA HCP5 promotes prostate cancer cell proliferation by acting as the sponge of miR‑4656 to modulate CEMIP expression.
    Hu R; Lu Z
    Oncol Rep; 2020 Jan; 43(1):328-336. PubMed ID: 31746434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
    Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
    [No Abstract]   [Full Text] [Related]  

  • 3. lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma.
    Zou S; Gao Y; Zhang S
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
    Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
    Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional role of long non-coding RNA CASC19/miR-140-5p/CEMIP axis in colorectal cancer progression
    Wang XD; Lu J; Lin YS; Gao C; Qi F
    World J Gastroenterol; 2019 Apr; 25(14):1697-1714. PubMed ID: 31011255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LINC00958 promotes tumor progression through miR-4306/CEMIP axis in osteosarcoma.
    Zhou Y; Mu T
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3182-3199. PubMed ID: 33928604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of long non‑coding RNA HCP5 suppresses the malignant behavior of retinoblastoma by sponging miR‑3619‑5p to target HDAC9.
    Zhu Y; Hao F
    Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33693951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A.
    Zhou Y; Li K; Dai T; Wang H; Hua Z; Bian W; Wang H; Chen F; Ai X
    Aging (Albany NY); 2021 Jun; 13(12):16267-16286. PubMed ID: 34148029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 10. LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge.
    Liang L; Xu J; Wang M; Xu G; Zhang N; Wang G; Zhao Y
    Cell Death Dis; 2018 Mar; 9(3):372. PubMed ID: 29515098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma.
    Tu Y; Cai Q; Zhu X; Xu M
    Braz J Med Biol Res; 2021; 54(2):e9161. PubMed ID: 33439936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lncRNAHCP5/microRNA-525-5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells.
    Wang L; He M; Fu L; Jin Y
    Exp Cell Res; 2020 Sep; 394(1):112129. PubMed ID: 32511950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer.
    Guo Z; He C; Yang F; Qin L; Lu X; Wu J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31481527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
    Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
    Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of Long Noncoding RNA HLA Complex P5 (
    Cheng R; Ji L; Su H; Wang L; Jia D; Yao X; Ji H
    Biomed Res Int; 2022; 2022():3092063. PubMed ID: 35769676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis.
    Wu M; Huang Y; Chen T; Wang W; Yang S; Ye Z; Xi X
    J Cell Mol Med; 2019 Jan; 23(1):29-38. PubMed ID: 30565858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells.
    He JH; Zhang JZ; Han ZP; Wang L; Lv YB; Li YG
    J Exp Clin Cancer Res; 2014 Sep; 33(1):72. PubMed ID: 25200485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA BLACAT1 Promotes Proliferation, Migration and Invasion of Prostate Cancer Cells via Regulating miR-29a-3p/DVL3 Axis.
    Liao B; Chen S; Li Y; Yang Z; Yang Y; Deng X; Ke S
    Technol Cancer Res Treat; 2021; 20():1533033820972342. PubMed ID: 33641528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a.
    Yu Y; Shen HM; Fang DM; Meng QJ; Xin YH
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4812-4819. PubMed ID: 30070314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.
    Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z
    Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.